Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | DNA topoisomerase I, putative | 0.0203 | 0.2504 | 1 |
Loa Loa (eye worm) | hypoxia-induced factor 1 | 0.0162 | 0.1934 | 0.6771 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0045 | 0.0301 | 0.0135 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0325 | 0.4198 | 1 |
Brugia malayi | glutathione reductase | 0.0041 | 0.0248 | 0.0447 |
Leishmania major | DNA topoisomerase IB, large subunit | 0.0152 | 0.1795 | 0.4276 |
Trypanosoma brucei | DNA topoisomerase type IB small subunit | 0.0051 | 0.0391 | 0.0932 |
Trichomonas vaginalis | ras-dva small GTPase, putative | 0.0062 | 0.0541 | 0.0638 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0056 | 0.0456 | 0.0527 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0045 | 0.0301 | 0.0718 |
Loa Loa (eye worm) | hypothetical protein | 0.0176 | 0.2123 | 0.748 |
Mycobacterium leprae | Probable fructose bisphosphate aldolase Fba | 0.0154 | 0.1817 | 1 |
Loa Loa (eye worm) | Ras protein let-60 | 0.0062 | 0.0541 | 0.1545 |
Plasmodium vivax | glutathione reductase, putative | 0.0041 | 0.0248 | 0.0502 |
Leishmania major | mitochondrial DNA polymerase beta | 0.0325 | 0.4198 | 1 |
Brugia malayi | hypoxia-induced factor 1 | 0.0162 | 0.1934 | 0.6771 |
Trypanosoma cruzi | DNA topoisomerase IB, large subunit, putative | 0.0152 | 0.1795 | 0.3916 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0045 | 0.0301 | 0.0718 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0045 | 0.0301 | 0.0718 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0041 | 0.0248 | 0.0447 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0315 | 0.4052 | 1 |
Loa Loa (eye worm) | DNA topoisomerase I | 0.0203 | 0.2504 | 0.8911 |
Brugia malayi | polk-prov protein | 0.0034 | 0.0151 | 0.0083 |
Toxoplasma gondii | thioredoxin reductase | 0.0041 | 0.0248 | 0.0502 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0315 | 0.4052 | 1 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0315 | 0.4052 | 1 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0103 | 0.1117 | 0.5418 |
Onchocerca volvulus | 0.0039 | 0.0221 | 0.0297 | |
Toxoplasma gondii | hypothetical protein | 0.0052 | 0.0411 | 0.1187 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0037 | 0.0202 | 0.0481 |
Schistosoma mansoni | microtubule-associated protein tau | 0.0744 | 1 | 1 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0093 | 0.0973 | 0.4719 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0315 | 0.4052 | 1 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0325 | 0.4198 | 1 |
Trichomonas vaginalis | dexras1, putative | 0.0062 | 0.0541 | 0.0638 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0103 | 0.1117 | 0.5418 |
Trypanosoma brucei | unspecified product | 0.0037 | 0.0202 | 0.0481 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0093 | 0.0973 | 0.4719 |
Brugia malayi | PAS domain containing protein | 0.0052 | 0.041 | 0.1054 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0045 | 0.0301 | 0.0718 |
Mycobacterium ulcerans | hypothetical protein | 0.0171 | 0.2061 | 1 |
Leishmania major | trypanothione reductase | 0.0041 | 0.0248 | 0.0591 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0045 | 0.0301 | 0.0718 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0093 | 0.0973 | 0.4719 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0045 | 0.0301 | 0.0718 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0103 | 0.1117 | 0.1705 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0315 | 0.4052 | 1 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0315 | 0.4052 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0045 | 0.0301 | 0.0718 |
Plasmodium vivax | topoisomerase I, putative | 0.0203 | 0.2504 | 1 |
Trypanosoma brucei | DNA polymerase beta thumb, putative | 0.0046 | 0.0317 | 0.0756 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0315 | 0.4052 | 1 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0041 | 0.0256 | 0.0128 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0045 | 0.0301 | 0.0135 |
Echinococcus granulosus | DNA topoisomerase 1 | 0.0203 | 0.2504 | 0.2419 |
Giardia lamblia | Fructose-bisphosphate aldolase | 0.0315 | 0.4052 | 1 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0103 | 0.1117 | 0.5418 |
Trypanosoma cruzi | DNA polymerase beta thumb, putative | 0.0046 | 0.0317 | 0.0176 |
Onchocerca volvulus | 0.0255 | 0.3224 | 1 | |
Schistosoma mansoni | aryl hydrocarbon receptor | 0.0052 | 0.041 | 0.0285 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0045 | 0.0301 | 0.0718 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0154 | 0.182 | 0.3978 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0045 | 0.0301 | 0.0437 |
Brugia malayi | Ras protein let-60 | 0.0062 | 0.0541 | 0.1545 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0093 | 0.0973 | 0.4719 |
Mycobacterium ulcerans | fructose-bisphosphate aldolase | 0.0154 | 0.1817 | 0.8675 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0224 | 0.2794 | 1 |
Brugia malayi | Pre-SET motif family protein | 0.0224 | 0.2794 | 1 |
Trypanosoma brucei | mitochondrial DNA polymerase beta-PAK | 0.0154 | 0.182 | 0.4334 |
Echinococcus multilocularis | DNA topoisomerase 1 | 0.0203 | 0.2504 | 0.2406 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0046 | 0.0317 | 0.0176 |
Trichomonas vaginalis | rap1 and, putative | 0.0062 | 0.0541 | 0.0638 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.0744 | 1 | 1 |
Trypanosoma brucei | trypanothione reductase | 0.0041 | 0.0248 | 0.0591 |
Leishmania major | mitochondrial DNA polymerase beta-PAK, putative | 0.0154 | 0.182 | 0.4334 |
Brugia malayi | Thioredoxin reductase | 0.0041 | 0.0248 | 0.0447 |
Brugia malayi | DNA topoisomerase I | 0.0203 | 0.2504 | 0.8911 |
Brugia malayi | Ras-related protein R-Ras2 | 0.0062 | 0.0541 | 0.1545 |
Trypanosoma brucei | DNA topoisomerase IB, large subunit | 0.0152 | 0.1795 | 0.4276 |
Entamoeba histolytica | fructose-1,6-bisphosphate aldolase, putative | 0.0315 | 0.4052 | 1 |
Trichomonas vaginalis | set domain proteins, putative | 0.0255 | 0.3224 | 0.7792 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.0151 | 0.0083 |
Schistosoma mansoni | DNA topoisomerase type I | 0.0152 | 0.1795 | 0.1688 |
Echinococcus granulosus | single minded 2 | 0.0039 | 0.0221 | 0.011 |
Trichomonas vaginalis | GTP-binding protein rit, putative | 0.0062 | 0.0541 | 0.0638 |
Trichomonas vaginalis | ral, putative | 0.0062 | 0.0541 | 0.0638 |
Echinococcus granulosus | ras gtpase | 0.0062 | 0.0541 | 0.0433 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0045 | 0.0301 | 0.0135 |
Mycobacterium tuberculosis | Probable fructose-bisphosphate aldolase Fba | 0.0154 | 0.1817 | 0.8817 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0093 | 0.0973 | 0.4719 |
Echinococcus granulosus | histone lysine methyltransferase setb | 0.0032 | 0.0129 | 0.0017 |
Entamoeba histolytica | fructose-1,6-bisphosphate aldolase, putative | 0.0315 | 0.4052 | 1 |
Trichomonas vaginalis | rheb, putative | 0.0062 | 0.0541 | 0.0638 |
Loa Loa (eye worm) | glutathione reductase | 0.0041 | 0.0248 | 0.0447 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0045 | 0.0301 | 0.0437 |
Trypanosoma brucei | mitochondrial DNA polymerase beta | 0.0325 | 0.4198 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0062 | 0.0541 | 0.1545 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0171 | 0.2061 | 1 |
Trypanosoma cruzi | DNA polymerase beta thumb, putative | 0.0046 | 0.0317 | 0.0176 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0041 | 0.0248 | 0.1204 |
Echinococcus granulosus | dna polymerase kappa | 0.0045 | 0.0301 | 0.0191 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0034 | 0.0151 | 0.0359 |
Treponema pallidum | fructose-bisphosphate aldolase | 0.0315 | 0.4052 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0045 | 0.0301 | 0.0718 |
Schistosoma mansoni | DNA topoisomerase type I | 0.0203 | 0.2504 | 0.2406 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0315 | 0.4052 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0045 | 0.0301 | 0.0135 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0045 | 0.0301 | 0.0718 |
Leishmania major | DNA topoisomerase type IB small subunit | 0.0051 | 0.0391 | 0.0932 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0041 | 0.0256 | 0.0145 |
Echinococcus multilocularis | ras gtpase | 0.0062 | 0.0541 | 0.0417 |
Brugia malayi | hypothetical protein | 0.0176 | 0.2123 | 0.748 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0034 | 0.0151 | 0.0359 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0045 | 0.0301 | 0.0718 |
Mycobacterium tuberculosis | Probable reductase | 0.0093 | 0.0973 | 0.4719 |
Trypanosoma cruzi | DNA topoisomerase type IB small subunit, putative | 0.0051 | 0.0391 | 0.0363 |
Schistosoma mansoni | single-minded | 0.0052 | 0.041 | 0.0285 |
Schistosoma mansoni | DNA topoisomerase type I | 0.0152 | 0.1795 | 0.1688 |
Brugia malayi | bHLH-PAS transcription factor | 0.0039 | 0.0221 | 0.0345 |
Plasmodium falciparum | topoisomerase I | 0.0203 | 0.2504 | 1 |
Echinococcus multilocularis | dna polymerase kappa | 0.0045 | 0.0301 | 0.0175 |
Echinococcus multilocularis | transfer RNA-Lys | 0.0039 | 0.0221 | 0.0093 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0041 | 0.0248 | 0.0502 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.